2024 : 11 : 23
Mahdi Khodaei Motlagh

Mahdi Khodaei Motlagh

Academic rank: Professor
ORCID: https://orcid.org/0000-0002-1281-7152
Education: PhD.
ScopusId: 41861677000
HIndex:
Faculty: Agriculture and Environment
Address:
Phone:

Research

Title
Replacing eCG with hCG in ewe laparoscopic artificial insemination protocols using hCG and a slow-release compound (Alhydrogel)
Type
JournalPaper
Keywords
alhydrogel, artificial insemination, estrus synchronization, equine chorionic gonadotropin, human chorionic gonadotropin
Year
2023
Journal Journal of Livestock Science and Technologies
DOI
Researchers Mohammad Yahyaei ، Mahdi Khodaei Motlagh ، sajad sabaghi ، MOHAMMAD Fallah

Abstract

Abstract The aim of this study was to investigate the effect of replacing equine chorionic gonadotropin (eCG) with human chorionic gonadotropin (hCG) and also improving the efficiency of hCG using a slow-release compound (alhydrogel) on the reproductive performance of Afshari ewes after laparoscopic artificial insemination. For this purpose, 48 Afshari ewes (2.5-4 years old with the mean weight of 68±2.5kg and an body condition score of 3.04±0.3 were treated with intravaginal controlled internal drug release (CIDR) for 14 days. The ewes were then divided into 4 groups: the first group: injection of eCG (400IU), 48 hours before CIDR removal (eCGS), the second group: injection of eCG (400IU) combined with alhydrogel, 48 hours before CIDR removal (eCGSR), the third group: injection of hCG (400IU), 48 hours before CIDR removal (hCGS) and the fourth group: injection of hCG (400IU) combined with alhydrogel, 48 hours before CIDR removal (hCGSR). The results showed that there was no significant difference between eCGSR and eCGS treatments in Measured parameters (P>0.05). The lowest pregnancy rate (25%) and fecundity (33%) were recorded in related to the hCGS treatment. However, in the hCGSR treatment, these parameters were increased to the values recorded in eCGSR and eCGS treatments. The results of this study showed that hCG in the presence of slow release compound can be a suitable substitute for eCG in the estrus synchronization protocol based on progesterone and eCG